ILC3s play a multifaceted role in cancer immunity, with anti-tumor effects primarily driven by their ability to recruit and activate effector cells, produce cytokines like IL-22 and TNF, form TLS, and present antigens. This evidence concerns the gene IL22 and neoplasm.